Guardant Health Reports First Quarter 2021 Financial Results

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2021. Recent Highlights Revenue of $78.7 million for...

Click to view original post